Medical News

---

• Lung-specific surfactant protein-D ‘strong predictor’ of CVD
• Updated warfarin guidelines released
• Neurocognition may predict clinical recovery in schizophrenia
• EBV infection linked to subclinical psychosis symptoms
• Childhood cancer survivors have long-term increased risk for further cancer
• Telephone counseling boosts LDL cholesterol reductions in PAD patients
• Dyslipidemia risk increased in female smokers
• High selenoprotein P linked to glucose dysregulation
• Inflammatory markers help predict Type 2 diabetes
• Updated warfarin guidelines released
• Call for personalized aspirin therapy guidelines
• CRT beneficial only in severely prolonged QRS cases
• Lifestyle interventions can positively alter cardiac risk factors
• Chinese ethnicity may raise cardiometabolic risk in men
• Prolonged TV viewing increases Type 2 diabetes risk
• Oral nitrates linked to adverse post-PCI events in diabetic patients
• CRT-D complications not associated with worse clinical outcomes
• Ambulance diversion increases mortality risk in AMI patients
• Beta-blockers linked to more favorable breast cancer disease characteristics

Lung-specific surfactant protein-D ‘strong predictor’ of CVD Posted: 16 Jun 2011 05:00 PM PDT Research suggests that lung-specific surfactant protein-D is a strong predictor of cardiovascular disease morbidity and mortality.

Updated warfarin guidelines released Posted: 15 Jun 2011 05:00 PM PDT The British Committee for Standards in Haematology has published updated guidelines on oral anticoagulation with warfarin.

Neurocognition may predict clinical recovery in schizophrenia Posted: 15 Jun 2011 05:00 PM PDT Neurocognition is associated with clinical recovery in patients with first-episode psychosis, although it is likely that other factors will need to be taken into account in order to accurately predict recovery, researchers from The Netherlands conclude.

EBV infection linked to subclinical psychosis symptoms Posted: 15 Jun 2011 05:00 PM PDT Epstein–Barr Virus is associated with subclinical psychotic symptoms in adolescents, Dutch and US clinicians have found.

Childhood cancer survivors have long-term increased risk for further cancer Posted: 15 Jun 2011 05:00 PM PDT Survivors of childhood cancer remain at increased risk for developing a subsequent primary neoplasm in their forties and beyond, UK study data show.

Telephone counseling boosts LDL cholesterol reductions in PAD patients Posted: 15 Jun 2011 05:00 PM PDT A telephone intervention that allows patients with peripheral arterial disease to request more intensive cholesterol-lowering therapy reduces low-density lipoprotein cholesterol more than health information alone, say US researchers.

Dyslipidemia risk increased in female smokers Posted: 15 Jun 2011 05:00 PM PDT Female smokers appear to be more likely to develop dyslipidemia than male smokers, particularly if they are heavy smokers, the results of a Korean study indicate.

High selenoprotein P linked to glucose dysregulation Posted: 15 Jun 2011 05:00 PM PDT High levels of circulating selenoprotein P are significantly higher in people with prediabetes or Type 2 diabetes than in those with normal glucose levels, report researchers.

Inflammatory markers help predict Type 2 diabetes Posted: 15 Jun 2011 05:00 PM PDT Research shows that addition of multiple inflammatory biomarkers, including C-reactive protein, interleukin-6, adiponectin, and leptin, to more traditional cardiometabolic risk factors, helps improve Type 2 diabetes and cardiovascular event risk prediction.

Updated warfarin guidelines released Posted: 15 Jun 2011 05:00 PM PDT The British Committee for Standards in Haematology has published updated guidelines on oral anticoagulation with warfarin.

Call for personalized aspirin therapy guidelines Posted: 15 Jun 2011 05:00 PM PDT US national guidelines for aspirin therapy should be personalized to take into account an individual's cardiovascular disease risk and possible adverse treatment effects, research suggests.

CRT beneficial only in severely prolonged QRS cases Posted: 15 Jun 2011 05:00 PM PDT Cardiac resynchronization therapy does not reduce adverse cardiac events in heart failure patients with moderately prolonged QRS intervals as previously thought, a study indicates.

Lifestyle interventions can positively alter cardiac risk factors Posted: 14 Jun 2011 05:00 PM PDT A successful lifestyle intervention program can improve existing cardiac risk factors and biomarkers of future cardiac disease in individuals with or at high risk for coronary heart disease, study results indicate.

Chinese ethnicity may raise cardiometabolic risk in men Posted: 14 Jun 2011 05:00 PM PDT Native Chinese men are more likely to have risk factors for cardiometabolic disease, namely elevated fasting blood glucose and reduced high-density lipoprotein cholesterol levels, than Caucasian men living in China, researchers suggest.

Prolonged TV viewing increases Type 2 diabetes risk Posted: 14 Jun 2011 05:00 PM PDT Results from a meta-analysis of published studies show that extended TV viewing is associated with increased risks for Type 2 diabetes, cardiovascular disease, and all-cause mortality.

Oral nitrates linked to adverse post-PCI events in diabetic patients Posted: 14 Jun 2011 05:00 PM PDT Study results suggest that long-term oral nitrate therapy may lead to significant side effects when given to patients with Type 2 diabetes after percutaneous coronary intervention, despite these drugs being commonly prescribed for angina and coronary artery disease.

CRT-D complications not associated with worse clinical outcomes Posted: 14 Jun 2011 05:00 PM PDT Italian researchers report that use of cardiac resynchronization therapy with an implantable cardioverter-defibrillator device is associated with more complications than use of either single- or dual-chamber defibrillators, but this does not lead to worse clinical outcomes.

Ambulance diversion increases mortality risk in AMI patients Posted: 14 Jun 2011 05:00 PM PDT US researchers suggest that 12 hours of ambulance diversion significantly increases the risk for mortality in patients suffering from acute myocardial infarction.

Beta-blockers linked to more favorable breast cancer disease characteristics Posted: 13 Jun 2011 05:00 PM PDT Use of propranolol, a nonselective β1/β2-adrenergic receptor antagonist, is associated with less advanced breast cancer at diagnosis and reduced disease-specific mortality, study findings indicate.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610